login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
STEVANATO GROUP SPA (STVN) Stock News
NYSE:STVN -
IT0005452658
-
Common Stock
22.62
USD
-0.23 (-1.01%)
Last: 8/22/2025, 8:04:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
STVN Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Zacks Investment Research
- Mentions:
USNA
USNA vs. STVN: Which Stock Is the Better Value Option?
18 days ago - By: Zacks Investment Research
- Mentions:
MDWD
Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates
18 days ago - By: Stevanato Group S.p.A.
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025
18 days ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
25 days ago - By: Zacks Investment Research
Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy?
a month ago - By: Stevanato Group S.p.A.
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
a month ago - By: Stevanato Group S.p.A.
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025
3 months ago - By: Zacks Investment Research
- Mentions:
GRFS
GRFS vs. STVN: Which Stock Is the Better Value Option?
4 months ago - By: Stevanato Group S.p.A.
Stevanato Group to Participate in Upcoming Investor Conferences
4 months ago - By: Zacks Investment Research
- Mentions:
FGEN
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates
4 months ago - By: Benzinga
- Mentions:
MSC
ELUT
ACIW
JYNT
...
Earnings Scheduled For May 8, 2025
4 months ago - By: Zacks Investment Research
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
4 months ago - By: Stevanato Group S.p.A.
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
4 months ago - By: Zacks Investment Research
- Mentions:
HRTX
Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates
4 months ago - By: Stevanato Group
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
5 months ago - By: Stevanato Group
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
6 months ago - By: Stevanato Group S.p.A.
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
6 months ago - By: Stevanato Group
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
8 months ago - By: Stevanato Group
Stevanato Group to Present at Upcoming Investor Conference
9 months ago - By: Stevanato Group
Stevanato Group to Present at Upcoming Investor Conferences
10 months ago - By: Stevanato Group
Stevanato Group Reports Financial Results for the Third Quarter of 2024
10 months ago - By: Stevanato Group S.p.A.
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
a year ago - By: Stevanato Group
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
a year ago - By: Stevanato Group
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
a year ago - By: Stevanato Group S.p.A.
Stevanato Group to Present at Upcoming Investor Conferences
a year ago - By: InvestorPlace
STVN Stock Earnings: Stevanato Gr Misses EPS, Beats Revenue for Q2 2024
a year ago - By: Stevanato Group S.p.A.
Stevanato Group Reports Financial Results for the Second Quarter of 2024
Please enable JavaScript to continue using this application.